Life Sciences Tools and Services
Company Overview of SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. provides products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics. The company’s Diagnostic and Biopharmaceutical Products segment offers controls and panels for the evaluation and quality control of infectious disease tests in clinical laboratories, blood banks, and in vitro diagnostic (IVD) manufacturing; and reagents and bioprocessing products for use in the discovery, development and manufacturing processes for drugs, vaccines, and diagnostic tests. It also provides diagnostic intermediates for use in manufacturing diagnostic test kits; cell culture additives and media that maintain viabi...
37 Birch Street
Milford, MA 01757
Founded in 1984
Key Executives for SeraCare Life Sciences, Inc.
Chief Executive Officer and President
Chief Financial Officer and Secretary
Vice President of Human Resources
Vice President of Manufacturing Operations
Compensation as of Fiscal Year 2014.
SeraCare Life Sciences, Inc. Key Developments
SeraCare Life Sciences Expands Genetic Portfolio with New Accurun(R) Product
Apr 8 14
SeraCare Life Sciences announced the launch of its new ACCURUN(R) 611 product, a robust product that demonstrates consistent performance over time. This reference material is designed to support detection of the Factor V Leiden mutation and the Factor II gene variant, as well as mutations in the Methlyenetetrahydrofolate reductase (MTHFR) gene that are associated with significant health problems. ACCURUN(R) 611 meets the needs of a broad range of molecular lab applications by providing heterozygous, mutant, or wild type scores for Factor II, Factor V, and MTHFR. It is ready-to-use genomic DNA manufactured from immortalized Peripheral Blood Mononuclear Cells (PBMCs) derived from human samples. Mutations were confirmed by a variety of commercial SNP genotyping assays, providing a robust challenge for all mutations in only two vials.
SeraCare Life Sciences Names Jack Wands as Founding Member of New Science Advisory Board
Feb 21 14
SeraCare Life Sciences has named Jack Wands as the founding member of the company's new Science Advisory Board. Wands is a professor of gastroenterology and medical science at Brown Medical School.
SeraCare Life Sciences, Inc. Unveils New Cytomegalovirus DNA Panel
Jan 9 14
SeraCare Life Sciences, Inc. has unveiled a new CMV DNA AccuSpan Linearity Panel. This new offering is a nine member panel made from serial dilutions of a cultured virus with established reactivity for CMV DNA. Cytomegalovirus (CMV) is one of the herpes viruses that infect cells and cause cellular enlargement. CMV infections are usually asymptomatic in healthy individuals but are considered a threat to unborn babies, infants and those who have weakened immune systems or are undergoing organ transplants. The CMV DNA AccuSpan Linearity Panel consists of seven positive members representing serial log dilutions of cultured virus in CMV DNA negative diluent, one negative member prepared from the diluent, and one member of diluent to perform additional dilutions as desired. The results of the CMV test were calibrated to the WHO international CMV Standard for Nucleic Acid Amplification Techniques and show a nearly 1:1 linearity.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries